Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Det Gamle Apotek A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.4% 2.4%   Bankruptcy risk   1.7% 2.9% 3.1% 2.3% 1.5% 0.9% 6.9% 6.9%   Credit score (0-100)   75 60 56 64 76 87 35 35   Credit rating   A BBB BBB BBB A A BBB BBB   Credit limit (kDKK)   9.8 0.0 0.0 0.3 81.6 1,424.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   18,344 20,873 21,417 22,345 22,096 27,971 0.0 0.0   EBITDA   2,070 -265 4,411 6,328 5,690 7,727 0.0 0.0   EBIT   1,601 -953 3,801 5,714 5,177 7,495 0.0 0.0   Pre-tax profit (PTP)   468.2 -2,143.8 2,762.4 4,506.8 3,526.8 5,711.9 0.0 0.0   Net earnings   324.0 -1,697.9 2,132.2 3,489.5 2,726.3 4,432.3 0.0 0.0   Pre-tax profit without non-rec. items   468 -2,144 2,762 4,507 3,527 5,712 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Tangible assets total   1,912 1,587 1,014 557 470 238 0.0 0.0   Shareholders equity total   3,565 1,867 3,999 7,488 9,215 12,647 11,147 11,147   Interest-bearing liabilities   10,896 17,276 4,922 8,623 10,568 8,655 0.0 0.0   Balance sheet total (assets)   21,228 27,232 25,396 41,125 38,319 40,032 11,147 11,147   Net Debt   10,598 17,219 4,868 8,527 10,389 8,529 -11,147 -11,147     See the entire balance sheet 1000.0 Volume  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   18,344 20,873 21,417 22,345 22,096 27,971 0.0 0.0   Gross profit growth   -7.2% 13.8% 2.6% 4.3% -1.1% 26.6% -100.0% 0.0%   Employees   43 55 42 37 37 43 0 0   Employee growth %   13.2% 27.9% -23.6% -11.9% 0.0% 16.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   21,228 27,232 25,396 41,125 38,319 40,032 11,147 11,147   Balance sheet change%   24.7% 28.3% -6.7% 61.9% -6.8% 4.5% -72.2% 0.0%   Added value   2,070.4 -265.1 4,410.9 6,328.4 5,791.7 7,727.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   515 -1,021 -1,183 -1,071 -599 -465 -238 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.7% -4.6% 17.7% 25.6% 23.4% 26.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.4% -3.9% 14.4% 17.2% 13.1% 19.2% 0.0% 0.0%   ROI %   11.0% -5.6% 26.0% 42.1% 27.6% 35.0% 0.0% 0.0%   ROE %   9.5% -62.5% 72.7% 60.8% 32.6% 40.5% 0.0% 0.0%   1000.0 Solidity  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Equity ratio %   16.8% 6.9% 15.7% 18.2% 24.0% 31.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   511.9% -6,496.2% 110.4% 134.7% 182.6% 110.4% 0.0% 0.0%   Gearing %   305.7% 925.5% 123.1% 115.2% 114.7% 68.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.2% 8.5% 9.4% 17.8% 17.4% 18.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Quick Ratio   0.4 0.2 0.5 0.6 0.6 0.7 0.0 0.0   Current Ratio   1.1 1.0 1.2 1.2 1.3 1.5 0.0 0.0   Cash and cash equivalent   297.4 56.5 53.3 96.1 178.3 125.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,450.9 -25.4 3,859.9 7,505.5 9,286.4 12,904.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   48 -5 105 171 157 180 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   48 -5 105 171 154 180 0 0   EBIT / employee   37 -17 90 154 140 174 0 0   Net earnings / employee   8 -31 51 94 74 103 0 0